These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis. Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW. Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948 [Abstract] [Full Text] [Related]
12. Long-term use of cyclosporine A does not adversely impact on clinical outcomes following renal transplantation. Lewis RM. Kidney Int Suppl; 1995 Dec 15; 52():S75-8. PubMed ID: 8587289 [Abstract] [Full Text] [Related]
14. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy. El-Agroudy AE, El-Dahshan K, Mahmoud K, Ismail AM, El-Baz M, Shokeir AA, Ghoneim MA. Exp Clin Transplant; 2008 Sep 15; 6(3):203-10. PubMed ID: 18954298 [Abstract] [Full Text] [Related]
15. The effect of transfusions on renal allograft survival in the cyclosporine era: a single center report. Egidi MF, Scott DH, Corry RJ. Clin Transplant; 1993 Jun 15; 7(3):240-4. PubMed ID: 10148843 [Abstract] [Full Text] [Related]
16. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J. Exp Clin Transplant; 2008 Jun 15; 6(2):113-7. PubMed ID: 18816237 [Abstract] [Full Text] [Related]